دورية أكاديمية
Providing Hemostatic and Blood Conservation Options for Jehovah's Witness Patients in a Large Medical System.
| العنوان: | Providing Hemostatic and Blood Conservation Options for Jehovah's Witness Patients in a Large Medical System. |
|---|---|
| المؤلفون: | Bai Y; Department of Pathology & Laboratory Medicine, TX, USA yu.bai@uth.tmc.edu., Castillo BS; Department of Pathology & Laboratory Medicine, TX, USA., Tchakarov A; Department of Pathology & Laboratory Medicine, TX, USA., Escobar MA; Department of Hematology and Gulf States Hemophilia & Thrombophilia Center, TX, USA., Cotton BA; Department of Surgery, UT Health McGovern Medical School and Memorial Hermann Hospital - Texas Medical Center, Houston, TX, USA., Holcomb JB; Department of Surgery, UT Health McGovern Medical School and Memorial Hermann Hospital - Texas Medical Center, Houston, TX, USA., Brown RE; Department of Pathology & Laboratory Medicine, TX, USA. |
| المصدر: | Annals of clinical and laboratory science [Ann Clin Lab Sci] 2016 Dec; Vol. 46 (6), pp. 654-661. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Institute for Clinical Science Country of Publication: United States NLM ID: 0410247 Publication Model: Print Cited Medium: Internet ISSN: 1550-8080 (Electronic) Linking ISSN: 00917370 NLM ISO Abbreviation: Ann Clin Lab Sci Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Philadelphia, Institute for Clinical Science. |
| مواضيع طبية MeSH: | Jehovah's Witnesses*, Hemostasis/*drug effects , Hemostatics/*pharmacology, Blood Loss, Surgical/prevention & control ; Humans ; Plasma/metabolism |
| مستخلص: | People of the Jehovah's Witness faith believe that they shall "abstain from blood." Because of this belief, we encounter the challenges from Jehovah's Witness patients who actively seek medical care for themselves and their children, but refuse the transfusion of blood products, which may result in increased morbidity and mortality in this patient population. With the development/availability of new hemostatic/coagulation products and the advances in medical technology, we, in collaboration with our clinical colleagues and our local Jehovah's Witness leadership, have developed a clinical guideline comprising medical protocol and surgical strategy for patients refusing blood products. Included in the medical protocol is an informative handout on related details to help treating physicians and patients make informed decisions about transfusion alternatives. Together, we have entered the medical protocol into the entire Memorial Hermann Hospital's electronic system. We report the detailed development and implementation process in order to share our experience and encourage others to develop their own management plan for this patient population. (© 2016 by the Association of Clinical Scientists, Inc.) |
| فهرسة مساهمة: | Keywords: Hemostasis alternatives; Jehovah’s Witness |
| المشرفين على المادة: | 0 (Hemostatics) |
| تواريخ الأحداث: | Date Created: 20161221 Date Completed: 20170113 Latest Revision: 20170113 |
| رمز التحديث: | 20240628 |
| PMID: | 27993880 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1550-8080 |
|---|